Document is current
Any future updates will be listed below
-
Authors
Humphries, Elizabeth M.
Ahn, Kwangmi
Kember, Rachel L. http://orcid.org/0000-0001-8820-2659
Lopes, Fabiana L.
Mocci, Evelina
Peralta, Juan M. http://orcid.org/0000-0002-8811-5579
Blangero, John http://orcid.org/0000-0001-6250-5723
Glahn, David C.
Goes, Fernando S. http://orcid.org/0000-0001-6262-8264
Zandi, Peter P. http://orcid.org/0000-0001-8423-2623
Kochunov, Peter
Van Hout, Cristopher
Shuldiner, Alan R.
Pollin, Toni I.
Mitchell, Braxton D.
Bucan, Maja
Hong, L. Elliot
McMahon, Francis J. http://orcid.org/0000-0002-9469-305X
Ament, Seth A. http://orcid.org/0000-0001-6443-7509
-
Funding
Funding for this research was provided by:
Brain and Behavior Research Foundation (NARSAD Young Investigator Award)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (U01 MH105632, U01 MH105630, R01 MH110437, U01 MH108148, U01 MH108148, ZIA MH002843)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
- License Information
-
More Information
Article History
Received: 1 July 2022
Revised: 19 February 2023
Accepted: 23 February 2023
First Online: 7 March 2023
Competing interests
: ARS is an employee of Regeneron Pharmaceuticals. LEH has received or plans to receive research funding or consulting fees on research projects from Mitsubishi, Your Energy Systems LLC, Neuralstem, Taisho, Heptares, Pfizer, Sound Pharma, IGC Pharma, Regeneron, and Takeda. SAA has received research funding from Oryzon Genomics LLC. All other authors declare no biomedical financial interests or potential competing interests.
